IRAK4 and neutropenia: Seven of the hospitalized MyD88- or IRAK-4–deficient patients developed neutropenia during the acute phase of infection (three of four moderate cases and four of six critical cases), whereas only two had a high ANC at a particular time point (ANC > 8,000/mm3; Fig. 4 D and Table S5).